| 1 | [SID22402184] | Active | AC50 | 1.843 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis [AID449756, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | AC50 | 1.843 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Beta Cell Apoptosis | | AID | 449756 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID22402184] | Active | Potency | 5.0119 | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) [AID2549, Type: confirmatory] | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 5.0119 [uM] | | BioAssay | qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) | | AID | 2549 | | BioAssay type | confirmatory | | Target | Chain A, Structure Of Human Recq-Like Helicase In Complex With A Dna Substrate [gi:282403581] | | PubMed | | | Data Table |  |
|
| 3 | [SID22402184] | Active | Potency | 5.8048 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 4 | [SID22402184] | Active | Potency | 5.8048 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 5 | [SID22402184] | Active | Potency | 5.8048 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 6 | [SID22402184] | Active | Potency | 5.8048 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 7 | [SID22402184] | Active | Potency | 5.8048 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 8 | [SID22402184] | Active | Potency | 5.8048 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 5.8048 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 9 | [SID22402184] | Active | AC50 | 7.23 | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick [AID463229, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | AC50 | 7.23 [uM] | | BioAssay | ATP-based Luminescence in the Absence of Cytokines Measured in Cell-Based System Using Plate Reader - 2061-06_Inhibitor_Dose_CherryPick | | AID | 463229 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID22402184] | Active | IC50 | 7.597 | Fluorescence-based biochemical high throughput dose response assay for inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID504742, Type: confirmatory] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | IC50 | 7.597 [uM] | | BioAssay | Fluorescence-based biochemical high throughput dose response assay for inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 504742 | | BioAssay type | confirmatory | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 11 | [SID22402184] | Active | Potency | 8.1995 | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504467, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504467 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 12 | [SID22402184] | Active | Potency | 8.9125 | qHTS for inhibitors of binding or entry into cells for Marburg Virus [AID540276, Type: confirmatory] | gene 4 small orf - Marburg virus [gi:420597] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for inhibitors of binding or entry into cells for Marburg Virus | | AID | 540276 | | BioAssay type | confirmatory | | Target | gene 4 small orf - Marburg virus [gi:420597] | | PubMed | | | Data Table |  |
|
| 13 | [SID22402184] | Active | Potency | 8.9125 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 14 | [SID22402184] | Active | Potency | 8.9125 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 15 | [SID22402184] | Active | Potency | 28.1838 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 16 | [SID22402184] | Active | Potency | 31.6228 | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 17 | [SID22402184] | Active | Potency | 31.6228 | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 18 | [SID22402184] | Active | Potency | 31.6228 | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 19 | [SID22402184] | Active | Potency | 31.6228 | qHTS assay for re-activators of p53 using a Luc reporter [AID504706, Type: confirmatory] | P53 [Homo sapiens] [gi:23491729] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS assay for re-activators of p53 using a Luc reporter | | AID | 504706 | | BioAssay type | confirmatory | | Target | P53 [Homo sapiens] [gi:23491729] | | PubMed | | | Data Table |  |
|
| 20 | [SID22402184] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 21 | [SID22402184] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 22 | [SID22402184] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) [AID463111, Type: screening] | RGS4 gene product [Homo sapiens] [gi:5032039] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4) | | AID | 463111 | | BioAssay type | screening | | Target | RGS4 gene product [Homo sapiens] [gi:5032039] | | PubMed | | | Data Table |  |
|
| 23 | [SID22402184] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 24 | [SID22402184] | Active | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 25 | [SID22402184] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 26 | [SID22402184] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 27 | [SID22402184] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 28 | [SID22402184] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 29 | [SID22402184] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. [AID435005, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis. | | AID | 435005 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID22402184] | Active | | | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression [AID818, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression | | AID | 818 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID22402184] | Active | | | Leishmania major promastigote HTS [AID1063, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | Leishmania major promastigote HTS | | AID | 1063 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID22402184] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 33 | [SID22402184] | Active | | | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity [AID623870, Type: screening] | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 623870 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor nuclear translocator [Homo sapiens] [gi:2702319] | | PubMed | | | Data Table |  |
|
| 34 | [SID22402184] | Active | | | uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays [AID1217, Type: screening] | Dihydrolipoamide dehydrogenase [Homo sapiens] [gi:17391426] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | uHTS Identification of Diaphorase Inhibitors and Chemcical Oxidizers: Counter Screen for Diaphorase-based Primary Assays | | AID | 1217 | | BioAssay type | screening | | Target | Dihydrolipoamide dehydrogenase [Homo sapiens] [gi:17391426] | | PubMed | | | Data Table |  |
|
| 35 | [SID22402184] | Active | | | Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID504635, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay for inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 504635 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 36 | [SID22402184] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID493244, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 493244 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 37 | [SID22402184] | Active | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 38 | [SID22402184] | Active | | | qHTS Assay for Inhibitors of the CtBP/E1A Interaction [AID651724, Type: screening] | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of the CtBP/E1A Interaction | | AID | 651724 | | BioAssay type | screening | | Target | CtBP interacting protein CtIP [Homo sapiens] [gi:1730321] | | PubMed | | | Data Table |  |
|
| 39 | [SID22402184] | Active | | | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction [AID651725, Type: screening] | six1 [Homo sapiens] [gi:1246761] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | qHTS Assay for Inhibitors of the Six1/Eya2 Interaction | | AID | 651725 | | BioAssay type | screening | | Target | six1 [Homo sapiens] [gi:1246761] | | PubMed | | | Data Table |  |
|
| 40 | [SID22402184] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1). [AID2130, Type: screening] | protein phosphatase methylesterase 1 [Homo sapiens] [gi:7706645] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1). | | AID | 2130 | | BioAssay type | screening | | Target | protein phosphatase methylesterase 1 [Homo sapiens] [gi:7706645] | | PubMed | | | Data Table |  |
|
| 41 | [SID22402184] | Active | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 42 | [SID22402184] | Active | | | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay [AID624354, Type: screening] | TNFRSF10B gene product [Homo sapiens] [gi:224494019] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Active | | BioAssay | uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay | | AID | 624354 | | BioAssay type | screening | | Target | TNFRSF10B gene product [Homo sapiens] [gi:224494019] | | PubMed | | | Data Table |  |
|
| 43 | [SID22402184] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 44 | [SID22402184] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 45 | [SID22402184] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 46 | [SID22402184] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 47 | [SID22402184] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 48 | [SID22402184] | Inactive | Potency | 0.1 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Inactive | | Potency | 0.1 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 49 | [SID22402184] | Inactive | Potency | 3.9811 | qHTS Assay for Rab9 Promoter Activators [AID485297, Type: confirmatory] | RAB9A gene product [Homo sapiens] [gi:4759012] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Inactive | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Rab9 Promoter Activators | | AID | 485297 | | BioAssay type | confirmatory | | Target | RAB9A gene product [Homo sapiens] [gi:4759012] | | PubMed | | | Data Table |  |
|
| 50 | [SID22402184] | Inactive | Potency | 6.3096 | qHTS Assay for NPC1 Promoter Activators [AID485313, Type: confirmatory] | NPC1 gene product [Homo sapiens] [gi:255652944] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 22402184 | | CID | 5933583 | | Outcome | Inactive | | Potency | 6.3096 [uM] | | BioAssay | qHTS Assay for NPC1 Promoter Activators | | AID | 485313 | | BioAssay type | confirmatory | | Target | NPC1 gene product [Homo sapiens] [gi:255652944] | | PubMed | | | Data Table |  |
|